Sugar Editorial Picks
Oct 01, 2009 -
A diagnosis of breast cancer is a life-changing moment that will affect almost 200,000 women this year. If faced with the diagnosis, one question your doctor will ask you to consider is whether or not you would remove a non-cancerous breast to protect yourself against the disease. The procedure is called prophylactic mastectomy, and a recent study shows that it's on the rise.
- 18 Comments
Nov 14, 2007 -
Some stories just inspire and motivate, and this is a sweet tale of two young girls, sisters in fact. After losing their grandfather to throat cancer, Molly and Carly Houlahan decided to raise funds to help fight cancer by raising bees and cultivating honey.
The girls, ages 13 and 15, took over their grandfather's hives and created Hives For Lives.
- 6 Comments
Nov 12, 2007 -
One thing I can wholeheartedly recommend to improve your health is quitting smoking. It decreases your chance of getting and dying from cancer, heart disease, and stroke. I am not saying you should quit today cold turkey, but if you did I would be so glad.
- 1 Comment
Oct 01, 2007 -
More than 20 years ago, two organizations created a partnership to increase breast cancer awareness. The partnership has grown to include a number of national public service organizations, professional medical associations, and government agencies all working together to build awareness of the disease, share information and provide access to screening services for countless women.
They claimed October as their month to highlight the issue, so today, Oct.
- 8 Comments
Nov 16, 2006 -
TODAY is the GREAT AMERICAN SMOKEOUT sponsored by the American Cancer Society. So if you are trying to quit smoking - today is the day. If you know someone who is trying to quit, you can be supportive and send them the link.
- 9 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Risk Factors
- Prevention and Lifestyle Fa...
- Symptoms
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Radiation
- Medications
- Chemotherapy
- Hormone Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
- In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
- In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.
Screening
- The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40.
- 0 Comments
Oct 19, 2009 -
Teaching at a yoga studio means I meet a lot of free-spirited folks. One student told me she stopped wearing underwire bras because she heard they can lead to breast cancer. This idea has been circling around that wearing a bra all day compresses the lymphatic system of the breast, resulting in accumulation of toxins that cause breast cancer.
- 19 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In September 2006, the Food and Drug Administration approved panitumumab (Vectibix) for the treatment of patients with colorectal cancer that has spread to other parts of the body following chemotherapy. Like cetuximab (Ertibux), panitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. Panitumumab is the first new colorectal cancer drug approved since 2004.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Prognosis
- Risk Factors
- Symptoms
- Conditions with Similar Sym...
- Screening and Diagnosis
- Tests to Determine Severity...
- Treatment
- Treatment Options by Stagin...
- Treatment for Localized Pro...
- Surgery
- Radiation Treatments
- Options if Treatments Fail...
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
New Guidelines for Localized Prostate Cancer
In 2007, the American Urological Association (AUA) released updated guidelines for treatment of localized prostate cancer. The guidelines recommend that:
- Patients should be classified as low, intermediate, or high risk, depending on their PSA levels, cancer stage, and tumor aggressiveness.
- Doctors need to consider patients’ personal preferences and quality of life concerns as well as their clinical status.
- Standard treatment options include active surveillance (watchful waiting), surgery, or radiation therapy. Initial androgen deprivation therapy (hormone therapy) is seldom recommended for localized prostate cancer.
New Guidelines for Androgen Deprivation Therapy
- The American Society of Clinical Oncology (ASCO) 2007 guidelines recommend that doctors delay androgen deprivation therapy for advanced prostate cancer until patients develop symptoms.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Causes
- Prevention
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Medications
- Radiation Therapy
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Ovarian Cancer Symptoms
Even early-stage ovarian cancer can produce symptoms, according to a 2007 consensus statement issued by the American Cancer Society, the Gynecologic Cancer Foundation, and the Society of Gynecologic Oncologists. Because ovarian cancer can grow very rapidly, early detection is extremely important. Contact your doctor (preferably a gynecologist) if you experience these symptoms on a daily basis for more than a few weeks:
- Bloating
- Pelvic or abdominal pain
- Difficulty eating or feeling full quickly
- Urgent or frequent urination
Hormone Replacement Therapy (HRT) Increases Ovarian Cancer Risk
- Post-menopausal women who use hormone replacement therapy (HRT) for more than 5 years are 20% more likely to develop ovarian cancer than women who do not use HRT, suggests a 2007 study in the Lancet.
- 0 Comments